NM_001374259.2:c.2337C>A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001374259.2(IL12RB2):​c.2337C>A​(p.Pro779Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.657 in 1,609,934 control chromosomes in the GnomAD database, including 352,274 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P779P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.61 ( 29460 hom., cov: 32)
Exomes 𝑓: 0.66 ( 322814 hom. )

Consequence

IL12RB2
NM_001374259.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.86

Publications

35 publications found
Variant links:
Genes affected
IL12RB2 (HGNC:5972): (interleukin 12 receptor subunit beta 2) The protein encoded by this gene is a type I transmembrane protein identified as a subunit of the interleukin 12 receptor complex. The coexpression of this and IL12RB1 proteins was shown to lead to the formation of high-affinity IL12 binding sites and reconstitution of IL12 dependent signaling. The expression of this gene is up-regulated by interferon gamma in Th1 cells, and plays a role in Th1 cell differentiation. The up-regulation of this gene is found to be associated with a number of infectious diseases, such as Crohn's disease and leprosy, which is thought to contribute to the inflammatory response and host defense. Several transcript variants encoding different isoforms and non-protein coding transcripts have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 1-67395837-C-A is Benign according to our data. Variant chr1-67395837-C-A is described in ClinVar as Benign. ClinVar VariationId is 1164694.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.86 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.671 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL12RB2NM_001374259.2 linkc.2337C>A p.Pro779Pro synonymous_variant Exon 17 of 17 ENST00000674203.2 NP_001361188.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL12RB2ENST00000674203.2 linkc.2337C>A p.Pro779Pro synonymous_variant Exon 17 of 17 NM_001374259.2 ENSP00000501329.1 Q99665-1

Frequencies

GnomAD3 genomes
AF:
0.614
AC:
93381
AN:
151976
Hom.:
29456
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.510
Gnomad AMI
AF:
0.628
Gnomad AMR
AF:
0.588
Gnomad ASJ
AF:
0.670
Gnomad EAS
AF:
0.382
Gnomad SAS
AF:
0.641
Gnomad FIN
AF:
0.751
Gnomad MID
AF:
0.592
Gnomad NFE
AF:
0.676
Gnomad OTH
AF:
0.594
GnomAD2 exomes
AF:
0.629
AC:
157582
AN:
250566
AF XY:
0.637
show subpopulations
Gnomad AFR exome
AF:
0.505
Gnomad AMR exome
AF:
0.570
Gnomad ASJ exome
AF:
0.668
Gnomad EAS exome
AF:
0.367
Gnomad FIN exome
AF:
0.748
Gnomad NFE exome
AF:
0.674
Gnomad OTH exome
AF:
0.641
GnomAD4 exome
AF:
0.662
AC:
964858
AN:
1457840
Hom.:
322814
Cov.:
40
AF XY:
0.663
AC XY:
480592
AN XY:
724676
show subpopulations
African (AFR)
AF:
0.502
AC:
16725
AN:
33284
American (AMR)
AF:
0.566
AC:
25156
AN:
44468
Ashkenazi Jewish (ASJ)
AF:
0.667
AC:
17369
AN:
26046
East Asian (EAS)
AF:
0.382
AC:
15137
AN:
39608
South Asian (SAS)
AF:
0.659
AC:
56782
AN:
86174
European-Finnish (FIN)
AF:
0.741
AC:
39555
AN:
53390
Middle Eastern (MID)
AF:
0.664
AC:
3818
AN:
5754
European-Non Finnish (NFE)
AF:
0.678
AC:
751591
AN:
1108926
Other (OTH)
AF:
0.643
AC:
38725
AN:
60190
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
17900
35800
53700
71600
89500
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19224
38448
57672
76896
96120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.614
AC:
93423
AN:
152094
Hom.:
29460
Cov.:
32
AF XY:
0.617
AC XY:
45861
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.510
AC:
21124
AN:
41460
American (AMR)
AF:
0.588
AC:
8976
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.670
AC:
2327
AN:
3472
East Asian (EAS)
AF:
0.381
AC:
1968
AN:
5160
South Asian (SAS)
AF:
0.641
AC:
3093
AN:
4822
European-Finnish (FIN)
AF:
0.751
AC:
7951
AN:
10588
Middle Eastern (MID)
AF:
0.582
AC:
171
AN:
294
European-Non Finnish (NFE)
AF:
0.676
AC:
45994
AN:
68000
Other (OTH)
AF:
0.590
AC:
1246
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1809
3619
5428
7238
9047
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
768
1536
2304
3072
3840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.640
Hom.:
44474
Bravo
AF:
0.592
Asia WGS
AF:
0.488
AC:
1697
AN:
3478
EpiCase
AF:
0.673
EpiControl
AF:
0.666

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 78% of patients studied by a panel of primary immunodeficiencies. Number of patients: 75. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.053
DANN
Benign
0.36
PhyloP100
-2.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229546; hg19: chr1-67861520; COSMIC: COSV52025994; COSMIC: COSV52025994; API